ExOlin - Insulin Delivery Device
A medical device for the physiological delivery of insulin, which is currently under development. Should make it possible to instantly administer an intraperitoneal (IP) injection of insulin using a simple subcutaneous injection (via an external connection to a syringe, pen, insulin pump, etc.). A biocompatible, non-biodegradable membrane that is permeable to insulin, but impermeable to the tissues of the recipient. Adaptable to many applications and pathologies, in addition to diabetes, which require the physiological delivery of drugs or active ingredients.
Benefits of the intraperitoneal delivery of insulin:
- Patients do not have to change their injection mode (syringe, pen, pump, etc.)
- IntraPeritoneal delivery is more physiological than subcutaneous delivery systems
- Improved long-term blood glucose stabilization
Services related to ExOlin
- A team of experts serving your technical needs
- Excellent quality work results in Defymed certification, according to the new ISO 13485:2016
- Patented medical devices that can be tailored to different drugs for many therapeutic applications
- Modifiable key parameters for tailoring our devices to your requests: type of materials, pore diameter and density, thicknesses, surface treatment, etc.
- Access to different in vitro and in vivo models that can validate the combination of your drugs with our medical devices.
Customer reviews
No reviews were found for ExOlin - Insulin Delivery Device. Be the first to review!